Heraeus Holdings GmbH
http://www.heraeus.com
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Heraeus Holdings GmbH
Interest In Korean Biotech IPOs Dips Amid Year-End Rush
Bioventures seeking IPOs in the South Korean stock market are having a tough time due to waning interest from investors. A surge in such offerings this year, coupled with the usual IPO rush seen at the end of each year, have resulted in several biotech companies withdrawing plans or raising funds short of initial targets.
Curetis Unveils Rapid Diagnostic For Implant And Tissue Infections
Curetis AG and its partner Heraeus Medical are ramping up for the European launch of a new molecular diagnostics assay designed to rapidly detect implant and tissue infections, including those associated with joint replacement surgery. The test will deliver a clinically actionable result in only four to five hours, compared with 10 days to two weeks for a microbiology culture.
Deals Shaping the Medical Industry (03/08)
The dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, pharmaceuticals, medical devices, and research/analytical instrumentation and reagents. All transactions are excerpted from Windhover's Strategic Transactions database, providing comprehensive transaction coverage from 1991 to the present.
LifeStream: A Financial Play in Devices Moves Upstream
First Chicago Equipty Capital, acting with advice from Garrett Capital Advisors LLC, formed LifeStream International LLC, a cardiopulmonary products company, out of three recent acquisitions: the cardiopulmonary products division of CR Bard Inc., certain assets of the cardiosurgery business of Minntech Corp., and Surgimedics Inc.,
Company Information
- Industry
- Medical Devices
- Miscellaneous
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice